Evidence map›Paper›PMID 29523826›Full record

ArticleScientific reports2018

PEG/Dextran Double Layer Influences Fe Ion Release and Colloidal Stability of Iron Oxide Nanoparticles.

M Rezaa Mohammadi, Andrey V Malkovskiy, Preetha Jothimuthu, Kwang-Min Kim, Mansi Parekh, Mohammed Inayathullah, Yan Zhuge, Jayakumar Rajadas

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. OAdvanced materials (Deerfield Beach, Fla.) · 2026
    Article
  2. Effect of clinically relevant iron oxide nanoparticles on macrophage polarization, tumor growth and tumor microenvironment modulation.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M Rezaa MohammadiBiomaterials and Advanced Drug Delivery Laboratory, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID 0000-0002-9370-3228
Andrey V MalkovskiyBiomaterials and Advanced Drug Delivery Laboratory, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Preetha JothimuthuBiomaterials and Advanced Drug Delivery Laboratory, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Kwang-Min KimBiomaterials and Advanced Drug Delivery Laboratory, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Mansi ParekhBiomaterials and Advanced Drug Delivery Laboratory, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Mohammed InayathullahBiomaterials and Advanced Drug Delivery Laboratory, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Yan ZhugeDepartment of Radiology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Jayakumar RajadasBiomaterials and Advanced Drug Delivery Laboratory, Stanford University School of Medicine, Stanford, CA, 94305, USA. jayraja@stanford.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite preliminary confidence on biosafety of polymer coated iron oxide nanoparticles (SPIONs), toxicity concerns have hampered their clinical translation. SPIONs toxicity is known to be due to catalytic activity of their surface and release of toxic Fe ions originating from the core biodegradation, leading to the generation of reactive oxygen species (ROS). Here, we hypothesized that a double-layer polymeric corona comprising of dextran as an interior, and polyethylene glycol (PEG) as an exterior layer better shields the core SPIONs. We found that ROS generation was cell specific and depended on SPIONs concentration, although it was reduced by sufficient PEG immobilization or 100 µM deferoxamine. 24 h following injection, PEGylated samples showed reduction of biodistribution in liver, heterogenous biodistribution profile in spleen, and no influence on NPs blood retention. Sufficient surface masking or administration of deferoxamine could be beneficial strategies in designing and clinical translation of future biomedical SPIONs.

Indexed as

AnimalsCells, CulturedColloidsDeferoxamineDextransDrug LiberationFemaleFerric CompoundsIronIron Chelating AgentsLiverMetal NanoparticlesMicePolyethylene GlycolsRAW 264.7 CellsReactive Oxygen SpeciesColloidsDeferoxamineDextransFerric Compoundsferric oxideIronIron Chelating AgentsPolyethylene GlycolsReactive Oxygen Species

Identifiers

PMID29523826
PMCPMC5844897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.